International Clinical Trial: A Phase I study evaluating the safety and effects of QX031N in healthy participants, participants with chronic obstructive pulmonary disease and participants with asthma

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ISRCTN22936350) titled 'A Phase I study evaluating the safety and effects of QX031N in healthy participants, participants with chronic obstructive pulmonary disease and participants with asthma' on Feb. 25.

Study Type: Interventional

Study Design: Allocation: Randomized controlled trial Masking: Blinded (masking used) Control: Placebo Assignment: Parallel Purpose: Treatment

Primary Sponsor: Qyuns Therapeutics Co., Ltd

Condition: Chronic obstructive pulmonary disease, asthma Respiratory

Intervention: Part A: SAD, healthy adult participants: Eligible healthy participants for the SAD part will be enrolled and randomized to receive a...